Concepedia

A. Benhammouda

AB

Statistics

Publications

8

Citations

383

H-Index

8

Active since

1993

Affiliations

Sorbonne Université(Current)

Pitié-Salpêtrière Hospital

A. Benhammouda is an author at Sorbonne Université specializing in oncology, tumor immunity, and tumor microenvironment.

Top concepts

Publications per year

1993–2022

8

Publications

8

Sequential chemoimmunotherapy with cisplatin, interleukin-2, and interferon alfa-2a for metastatic melanoma.

D. Khayat, Christian Borel, J.M. Tourani et al. · Journal of Clinical Oncology · 1993 · 149 citations

Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: results of a sequential nonrandomized phase II study. Subcutaneous Administration Propeukin Program Cooperative Group.

J.M. Tourani, C. Pfister, J.F. Berdah et al. · Journal of Clinical Oncology · 1998 · 78 citations

Endogenous interleukin 6 levels in patients with metastatic malignant melanoma: correlation with tumor burden.

Roger Mouawad, A. Benhammouda, Olivier Rixe et al. · PubMed · 1996 · 70 citations

, , +16

Salpêtrière Hospital experience with biochemotherapy in metastatic melanoma.

Antoine Ec, A. Benhammouda, Anne Bernard et al. · PubMed · 1997 · 27 citations

Phase II Study of Sequential Administration of Docetaxel Followed by Doxorubicin and Cyclophosphamide as First-Line Chemotherapy in Metastatic Breast Cancer

D. Khayat, P. Chollet, Éric-Charles Antoine et al. · Journal of Clinical Oncology · 2001 · 19 citations

1–5 of 8